MedPath

Treatment of knee osteoarthritis using adipose tissue-derived stem cells

Phase 1
Conditions
Knee osteoarthiritis
Registration Number
JPRN-jRCTb050220048
Lead Sponsor
Satoshi Sobajima
Brief Summary

There were no entries by the end of the research period for this regenerative medicine, etc., and regenerative medicine, etc. was not provided.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
5
Inclusion Criteria

Over 20 years old when obtaining consent
-No improvement in standard conservative therapy for insurance indication
-Don't request surgical treatment at the time of obtaining consent
-Obtain written consent sufficient explanation about this study
-Able to comply with a fixed schedule

Exclusion Criteria

-Patients who have difficulty with subcutaneous liposuction
-Patients with cancer
-Patients who are using anti-cancer drugs, biologics or immunosuppressants
-Patients with active infection
-Patients who have recieved this treatmentwithin a month
-Patients with serious complicaitons such asheart disease, liver diseaes, lung disease, kidny disease, bleeding tendency, uncontroled diabetes, hypertension, etc.
-Patients with a history of drug sensitivity to anesthetics
-Other patients judged inappropriate by doctors

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath